InsiderTrades.com logo

AARD Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $730,302.00
Insider Selling (Last 12 Months): $0.00

Aardvark Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aardvark Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aardvark Therapeutics Share Price & Price History

Current Price: $12.40
Price Change: ▲ Price Increase of +0.47 (3.94%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for AARD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aardvark Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2025Tien-Li LeeCEOBuy10,000$9.66$96,600.001,543,384View SEC Filing Icon  
9/12/2025Tien-Li LeeCEOBuy5,000$8.50$42,500.001,533,384View SEC Filing Icon  
9/11/2025Tien-Li LeeCEOBuy6,000$7.82$46,920.001,528,384View SEC Filing Icon  
9/10/2025Tien-Li LeeCEOBuy9,000$7.91$71,190.001,522,384View SEC Filing Icon  
9/9/2025Nelson SunCFOBuy6,000$8.07$48,420.00105,484View SEC Filing Icon  
2/14/2025Nelson SunCFOBuy10,000$16.00$160,000.0099,484View SEC Filing Icon  
2/14/2025Tien-Li LeeCEOBuy16,542$16.00$264,672.001,496,175View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aardvark Therapeutics (NASDAQ:AARD)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AARD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aardvark Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/1/2025Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.444%Search for SEC Filing on Google Icon
11/17/2025Laurion Capital Management LP1,049,721$13.95M0.2%+6.1%4.838%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC319,623$4.25M0.0%N/A1.473%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC1,359,883$18.07M0.0%+5.9%6.268%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE23,930$0.32M0.0%+199.5%0.110%Search for SEC Filing on Google Icon
11/17/2025Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.446%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC253,752$3.37M0.0%-9.1%1.169%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP63,569$0.85M0.0%N/A0.293%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC22,000$0.29M0.0%N/A0.101%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG54,728$0.73M0.0%+5.4%0.252%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets56,546$0.75M0.0%+59.3%0.261%Search for SEC Filing on Google Icon
11/12/2025Cresset Asset Management LLC146,783$1.95M0.0%N/A0.676%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.555,721$7.39M0.0%+20.6%2.561%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund3,823$51K0.0%-47.6%0.018%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE7,989$0.11M0.0%+72.9%0.037%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.175,000$2.37M0.0%-30.0%0.806%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,091$42K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund7,300$99K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC136,927$1.85M0.0%+129.7%0.631%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.20,311$0.15M0.0%N/A0.094%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.20,311$0.15M0.0%N/A0.094%Search for SEC Filing on Google Icon
5/16/2025Cormorant Asset Management LP800,189$6.01M0.5%N/A3.688%Search for SEC Filing on Google Icon
5/16/2025Adage Capital Partners GP L.L.C.250,000$1.88M0.0%N/A1.152%Search for SEC Filing on Google Icon
5/15/2025Braidwell LP500,000$3.76M0.1%N/A2.305%Search for SEC Filing on Google Icon
5/14/2025Walleye Capital LLC11,730$88K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/8/2025Decheng Capital LLC3,917,299$29.42M8.3%N/A18.055%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aardvark Therapeutics logo
Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
Read More on Aardvark Therapeutics

Today's Range

Now: $12.40
Low: $11.90
High: $12.83

50 Day Range

MA: $11.96
Low: $9.26
High: $17.41

52 Week Range

Now: $12.40
Low: $4.88
High: $19.58

Volume

241,894 shs

Average Volume

163,275 shs

Market Capitalization

$269.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aardvark Therapeutics?

Aardvark Therapeutics' top insider investors include:
  1. Tien-Li Lee (CEO)
  2. Nelson Sun (CFO)
Learn More about top insider investors at Aardvark Therapeutics.

Who are the major institutional investors of Aardvark Therapeutics?

Aardvark Therapeutics' top institutional shareholders include:
  1. Citadel Advisors LLC — 6.27%
  2. Laurion Capital Management LP — 4.84%
  3. Vanguard Group Inc. — 2.56%
  4. Millennium Management LLC — 1.47%
  5. Schonfeld Strategic Advisors LLC — 1.17%
  6. Cresset Asset Management LLC — 0.68%
Learn More about top institutional investors of Aardvark Therapeutics stock.

Which institutional investors are selling Aardvark Therapeutics stock?

During the last quarter, AARD stock was sold by these institutional investors:
  1. Schonfeld Strategic Advisors LLC
  2. New York State Common Retirement Fund

Which institutional investors are buying Aardvark Therapeutics stock?

Within the previous quarter, AARD stock was bought by institutional investors including:
  1. Millennium Management LLC
  2. Cresset Asset Management LLC
  3. Vanguard Group Inc.
  4. Citadel Advisors LLC
  5. Two Sigma Investments LP
  6. Laurion Capital Management LP
  7. Bridgeway Capital Management LLC
  8. BNP Paribas Financial Markets
In the last year, these company insiders have bought Aardvark Therapeutics stock:
  1. Tien-Li Lee (CEO)
  2. Nelson Sun (CFO)
Learn More investors buying Aardvark Therapeutics stock.